Gene expression as a target for new drug discovery.
Over the last 7 years we have carried out a major research effort focused on gene transcription as a novel approach to drug discovery. The goal is to identify small molecular weight compounds that modulate the expression of a target gene in a specific manner, thereby either increasing or decreasing the concentration of the corresponding protein product. Transcriptional modulation not only provides a potential means to replace recombinant proteins as drugs, but also provides a novel approach to manipulate key gene targets in many therapeutic areas. This article describes some of the features and advantages of transcription-based pharmaceuticals and illustrates how this approach can be applied to drug discovery with a program we are pursuing to identify new treatments for sickle cell disease and beta-thalassemia.
Heguy
A
A
Oncogene Science, Inc., Uniondale, NY 11553, USA.
Stewart
A A
AA
Haley
J D
JD
Smith
D E
DE
Foulkes
J G
JG
D000755:Anemia, Sickle Cell / Q000188:drug therapy; D015195:Drug Design; D004353:Drug Evaluation, Preclinical; D015870:Gene Expression / Q000187:drug effects*; D005786:Gene Expression Regulation; D005914:Globins / Q000235:genetics; D006801:Humans
D005914:Globins